Clinical data statistics showed that HCC patients with a high expression of hnRNPA2B1 had poorer differentiation of HCC tissues (poor differentiation, 36.8% versus 11.8%, p = 0.026) and shorter overall survival (median survival, 27.5 months versus 6.0 months, p = 0.0471) (Figure 7J; Table S3). Here, HNRNPA2B1 is linked to hepatocellular carcinoma.